Pediatrics
Neonatal cholestasis
A thriving infant can still have biliary atresia. Persistent jaundice or pale stools calls for fractionated bilirubin and a time-sensitive evaluation.
Partially covered in the main question banks · 18 main-bank entries · 24 linked PDF entries · 0 generated drills
Prerequisites and related lessons
- Cholestasis in pediatrics
Curriculum reference · Official College Textbook – Digestive Disorders – Part 2, pp. 345–347. Lesson adapted from Pediatric hepatology and metabolic disease.
Topic map
- Triggerpersistent jaundice, pale stools or prior elevated direct bilirubin
- Firstfractionate and assess stability
- Time-criticaldetect biliary atresia and assess for sepsis/metabolic disease
- Definitivespecialist cholangiography and early Kasai when indicated
Scroll the diagram to see all labels.
Recognition and initial assessment
- Initial assessment
- Recognize persistent jaundice/pale stool and check total/direct bilirubin
- Confirmation or next test
- Urgent specialist evaluation; operative cholangiography is a reference test for biliary atresia
Evaluate jaundice persisting after about two weeks with total and direct bilirubin. Direct bilirubin ≥1 mg/dL at 2–4 weeks [AAP biliary atresia clinical report] warrants urgent consultation in the appropriate screening context. In the first days, interpret direct/conjugated bilirubin against the laboratory reference range and trend. Infant jaundice with acholic stool or dark urine [Pediatric Mid Chol Q8–9 · Old p. 114 Q7] should prompt assessment even before two weeks. Review stool directly or via a color card, assess feeding and weight, birth history, parenteral nutrition, infection and newborn screen. A well appearance or intermittently pigmented stools do not exclude early biliary atresia.
Initial work-up includes glucose, bilirubin fractions, ALT/AST, GGT, albumin, PT/INR, CBC and abdominal ultrasound. With illness or liver dysfunction, evaluate for sepsis including UTI, treatable metabolic disorders including galactosemia and tyrosinemia, and neonatal infection as indicated. The course lists idiopathic neonatal hepatitis; use it after evaluating other causes. Alpha-1 antitrypsin deficiency, Alagille syndrome, genetic transporter/bile acid disorders and parenteral nutrition are important alternatives. An ill infant after milk with hypoglycemia and coagulopathy requires urgent stabilization and a metabolic/sepsis pathway even while evaluating bile flow.
Biliary atresia pathogenesis and clinical features
Biliary atresia [Pediatric Mid Chol Q1/Q6/Q8/Q9 · Old] is progressive fibro-inflammatory obliteration of bile ducts around birth. Book II divides it into type I (common bile duct), type II (common hepatic duct), and type III (at the porta hepatis, most common). Some cases have splenic and laterality anomalies, abnormal vena cava or congenital heart findings. Persistent conjugated jaundice, dark urine, hepatomegaly and pale stools are characteristic. A small/abnormal gallbladder can occur. Huge distension is not the classic finding. Delay risks cirrhosis, portal hypertension, malabsorption and vitamin deficiency.
Tests and definitive management
Ultrasound can show abnormal gallbladder, absent biliary landmarks or triangular cord sign. A normal scan does not rule out atresia. A HIDA scan tracks excretion into bowel; absent excretion is nonspecific and can occur in severe intrahepatic disease. MRCP is selective and limited by very small ducts. Liver biopsy may show ductular proliferation, bile plugs and portal fibrosis. Operative cholangiography [Pediatric Mid Chol Q9 · Old] assesses duct patency and is the course reference standard before definitive surgery when needed. Do not let serial low-yield tests delay referral.
Kasai portoenterostomy [Pediatric Mid Chol Q6/Q9 · Old] removes the fibrotic extrahepatic remnant and brings a Roux-en-Y limb to the porta hepatis to drain residual microscopic ducts. Earlier surgery generally improves the chance of clearing jaundice. The exam says the statement “after 60 days” is false. The classic teaching urges surgery before 60 days and modern pathways seek action earlier whenever feasible. Monitor jaundice clearance, cholangitis, growth, fat-soluble vitamins and portal hypertension. Early or later transplant may be needed after an unsuccessful Kasai or with progressive disease.
Distinguishing causes and exam traps
Alagille syndrome [Pediatric Mid Chol Q10 · Old] points to facies, murmur and interlobular bile duct paucity. A cystic dilation suggests choledochal cyst, though cystic biliary atresia can mimic it. Sepsis, TORCH and metabolic liver injury are intrahepatic and can overlap clinically. Physiological jaundice and breast milk jaundice are predominantly unconjugated. “Dark urine” and “clay-colored stool” refer to opposite destinations of bile pigment.
Diagnostic and management pathways
- Persistent jaundice, pale stools or prior direct bilirubin rise → total/direct bilirubin immediately
- Direct hyperbilirubinemia → assess INR/glucose and arrange urgent pediatric hepatology evaluation
- Ultrasound and targeted infectious/metabolic tests in parallel → expedited biliary atresia work-up
- Atresia confirmed → timely Kasai when appropriate → monitor clearance, complications and transplant need
Compare at a glance
| Cause | Helpful clue | Key direction |
|---|---|---|
| Biliary atresia | Progressive pale stool, dark urine and direct jaundice | Urgent referral, cholangiography as indicated and early Kasai |
| Choledochal cyst | Cystic biliary dilation or abdominal mass | Ultrasound and specialized biliary imaging/surgical review |
| Alagille syndrome | Murmur, typical facies, bile duct paucity | Syndromic and molecular evaluation |
| Galactosemia/sepsis | Sick neonate, feeding-related symptoms or hypoglycemia | Prompt stabilization, cultures and metabolic evaluation |
| Physiological/breast milk jaundice | Mostly unconjugated bilirubin, often thriving | Confirm fractions when persistent |
Supplementary clarification – not directly stated in the uploaded materials. Clinical references · AAP clinical report on early identification of biliary atresia · NASPGHAN/ESPGHAN infant cholestasis guideline
Exam words
- Direct bilirubin ≥1 mg/dL at 2–4 weeks [AAP biliary atresia clinical report]
- acholic stool or dark urine [Pediatric Mid Chol Q8–9 · Old p. 114 Q7]
- Biliary atresia [Pediatric Mid Chol Q1/Q6/Q8/Q9 · Old]
- Operative cholangiography [Pediatric Mid Chol Q9 · Old]
- Kasai portoenterostomy [Pediatric Mid Chol Q6/Q9 · Old]
- Alagille syndrome [Pediatric Mid Chol Q10 · Old]
Practice questions
Rapid revision sheet
Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.
- Direct bilirubin ≥1 mg/dL at 2–4 weeks [AAP biliary atresia clinical report]
- acholic stool or dark urine [Pediatric Mid Chol Q8–9 · Old p. 114 Q7]
- Biliary atresia [Pediatric Mid Chol Q1/Q6/Q8/Q9 · Old]
- Operative cholangiography [Pediatric Mid Chol Q9 · Old]
- Kasai portoenterostomy [Pediatric Mid Chol Q6/Q9 · Old]
- Alagille syndrome [Pediatric Mid Chol Q10 · Old]
Official College Textbook – Digestive Disorders – Part 2, pp. 345–347
Active recall
Which urgent diagnosis should be investigated in an infant with persistent jaundice, high direct bilirubin and acholic stools?
Biliary atresia. Early specialist evaluation matters because delay can compromise outcomes after hepatoportoenterostomy.
Official College Textbook – Digestive Disorders – Part 2, pp. 345–347
Recall the diagnostic and management pathway from memory.
Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.
- Persistent jaundice, pale stools or prior direct bilirubin rise → total/direct bilirubin immediately
- Direct hyperbilirubinemia → assess INR/glucose and arrange urgent pediatric hepatology evaluation
- Ultrasound and targeted infectious/metabolic tests in parallel → expedited biliary atresia work-up
- Atresia confirmed → timely Kasai when appropriate → monitor clearance, complications and transplant need